These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27588699)

  • 1. Relative effect potency estimates of dioxin-like activity for dioxins, furans, and dioxin-like PCBs in adults based on cytochrome P450 1A1 and 1B1 gene expression in blood.
    Wimmerová S; van den Berg M; Chovancová J; Patayová H; Jusko TA; van Duursen MB; Palkovičová Murínová Ľ; Canton RF; van Ede KI; Trnovec T
    Environ Int; 2016 Nov; 96():24-33. PubMed ID: 27588699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential relative effect potencies of some dioxin-like compounds in human peripheral blood lymphocytes and murine splenic cells.
    van Ede KI; Gaisch KP; van den Berg M; van Duursen MB
    Toxicol Lett; 2014 Apr; 226(1):43-52. PubMed ID: 24472611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative effect potency estimates of dioxin-like activity for dioxins, furans, and dioxin-like PCBs in adults based on two thyroid outcomes.
    Trnovec T; Jusko TA; Šovčíková E; Lancz K; Chovancová J; Patayová H; Palkovičová L; Drobná B; Langer P; Van den Berg M; Dedik L; Wimmerová S
    Environ Health Perspect; 2013 Aug; 121(8):886-92. PubMed ID: 23665575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female mice after a single oral dose.
    van Ede KI; Andersson PL; Gaisch KP; van den Berg M; van Duursen MB
    Environ Health Perspect; 2013 Jul; 121(7):847-53. PubMed ID: 23674508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the CYP1A1 mRNA dose-response in human keratinocytes indicates that relative potencies of dioxins, furans, and PCBs are species and congener specific.
    Sutter CH; Bodreddigari S; Sutter TR; Carlson EA; Silkworth JB
    Toxicol Sci; 2010 Dec; 118(2):704-15. PubMed ID: 20819910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of toxic equivalency factor distributions in probabilistic risk assessments for dioxins, furans, and PCBs.
    Finley BL; Connor KT; Scott PK
    J Toxicol Environ Health A; 2003 Mar; 66(6):533-50. PubMed ID: 12712595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility.
    van Duursen MB; Sanderson JT; van den Berg M
    Toxicol Sci; 2005 May; 85(1):703-12. PubMed ID: 15659568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitivity analysis using alternative toxic equivalency factors to estimate U.S. dietary exposures to dioxin-like compounds.
    Parvez S; Evans AM; Lorber M; Hawkins BS; Swartout JC; Teuschler LK; Rice GE
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):278-84. PubMed ID: 23973911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative potencies of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners to induce cytochrome P4501A mRNA in a zebrafish liver cell line.
    Henry TR; Nesbit DJ; Heideman W; Peterson RE
    Environ Toxicol Chem; 2001 May; 20(5):1053-8. PubMed ID: 11337868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female rats after a single oral dose.
    van Ede KI; Andersson PL; Gaisch KP; van den Berg M; van Duursen MB
    Arch Toxicol; 2014 Mar; 88(3):637-46. PubMed ID: 24363026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus toxicity factors for polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls combining in silico models and extensive in vitro screening of AhR-mediated effects in human and rodent cells.
    Larsson M; van den Berg M; Brenerová P; van Duursen MB; van Ede KI; Lohr C; Luecke-Johansson S; Machala M; Neser S; Pěnčíková K; Poellinger L; Schrenk D; Strapáčová S; Vondráček J; Andersson PL
    Chem Res Toxicol; 2015 Apr; 28(4):641-50. PubMed ID: 25654323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling and assaying dioxin-like biological effects for both dioxin-like and certain non-dioxin-like compounds.
    Wilkes JG; Hass BS; Buzatu DA; Pence LM; Archer JC; Beger RD; Schnackenberg LK; Halbert MK; Jennings L; Kodell RL
    Toxicol Sci; 2008 Mar; 102(1):187-95. PubMed ID: 18065775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the concentrations of polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, and polychlorinated biphenyls in maternal blood and those in breast milk.
    Todaka T; Hirakawa H; Kajiwara J; Hori T; Tobiishi K; Yasutake D; Onozuka D; Sasaki S; Miyashita C; Yoshioka E; Yuasa M; Kishi R; Iida T; Furue M
    Chemosphere; 2010 Jan; 78(2):185-92. PubMed ID: 19850319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicokinetics of dioxins and other organochlorine compounds in Japanese people: association with hepatic CYP1A2 expression levels.
    Watanabe MX; Kunisue T; Ueda N; Nose M; Tanabe S; Iwata H
    Environ Int; 2013 Mar; 53():53-61. PubMed ID: 23333656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood levels of dioxins, furans, dioxin-like PCBs, and TEQs in general populations: a review, 1989-2010.
    Consonni D; Sindaco R; Bertazzi PA
    Environ Int; 2012 Sep; 44():151-62. PubMed ID: 22364893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative effective potencies of dioxin-like compounds in rodent and human lung cell models.
    Strapáčová S; Brenerová P; Krčmář P; Andersson P; van Ede KI; van Duursen MBM; van den Berg M; Vondráček J; Machala M
    Toxicology; 2018 Jul; 404-405():33-41. PubMed ID: 29738842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.